Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $10046.0.

  • Onconetix's Receivables - Other fell 9723.25% to $10046.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10046.0, marking a year-over-year decrease of 9723.25%. This contributed to the annual value of $159000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Onconetix's Receivables - Other is $10046.0, which was down 9723.25% from $12599.0 recorded in Q2 2025.
  • Over the past 5 years, Onconetix's Receivables - Other peaked at $522000.0 during Q3 2023, and registered a low of $10046.0 during Q3 2025.
  • Moreover, its 3-year median value for Receivables - Other was $250308.0 (2024), whereas its average is $228223.3.
  • Per our database at Business Quant, Onconetix's Receivables - Other surged by 5742.64% in 2024 and then tumbled by 9723.25% in 2025.
  • Onconetix's Receivables - Other (Quarter) stood at $159000.0 in 2023, then soared by 57.43% to $250308.0 in 2024, then crashed by 95.99% to $10046.0 in 2025.
  • Its last three reported values are $10046.0 in Q3 2025, $12599.0 for Q2 2025, and $11057.0 during Q1 2025.